Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

This study has been completed.
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by:
University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT00405171
First received: November 27, 2006
Last updated: October 27, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: February 2006
  Estimated Primary Completion Date: No date given
Publications: